Evidence map›Paper›PMID 39198397›Full record

ArticleNature communications2024

Leveraging long-lived arenium ions in superacid for meta-selective methylation.

Paul Bourbon, Kassandra Vitse, Agnès Martin-Mingot, Hugo Geindre, Frédéric Guégan, Bastien Michelet, Sébastien Thibaudeau

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paul BourbonUniversité de Poitiers, CNRS, Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), 86073, Poitiers, Cedex 9, France.
Kassandra VitseUniversité de Poitiers, CNRS, Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), 86073, Poitiers, Cedex 9, France.
Agnès Martin-MingotUniversité de Poitiers, CNRS, Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), 86073, Poitiers, Cedex 9, France.
Hugo GeindreUniversité de Poitiers, CNRS, Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), 86073, Poitiers, Cedex 9, France.ORCID http://orcid.org/0000-0002-4895-6365
Frédéric GuéganUniversité de Poitiers, CNRS, Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), 86073, Poitiers, Cedex 9, France.ORCID http://orcid.org/0000-0002-4932-8643
Bastien MicheletUniversité de Poitiers, CNRS, Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), 86073, Poitiers, Cedex 9, France. bastien.michelet@univ-poitiers.fr.ORCID http://orcid.org/0000-0002-3248-5781
Sébastien ThibaudeauUniversité de Poitiers, CNRS, Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), 86073, Poitiers, Cedex 9, France. sebastien.thibaudeau@univ-poitiers.fr.ORCID http://orcid.org/0000-0002-6246-5829

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electrophilic aromatic substitution is one of the most mechanistically studied reactions in organic chemistry. However, precluded by innate substituent effects, the access to certain substitution patterns remains elusive. While selective C-H alkylation of biorelevant molecules is eagerly awaited, especially for the insertion of a methyl group whose magic effect can boost lead molecules potency, one of the most obvious strategies would rely on electrophilic aromatic substitution. Yet, the historical Friedel-Crafts methylation remains to date poorly selective and limited to activated simple aromatics. Here, we report the development of a selective electrophilic methylation enabling the direct access to highly desirable 1,3-disubstituted arenes. This study demonstrates that this reaction is driven by the generation of long-lived arenium intermediates generated by protonation in superacid and can be applied to a large variety of functionalized (hetero)aromatics going from standard building blocks to active pharmaceutical ingredients.

Identifiers

PMID39198397
PMCPMC11358458

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.